Testing next-generation sequencing in neutropenic sepsis
Part of Blood & lymphatic clinical trials.
This trial studies whether advanced genetic testing (next-generation sequencing) can help doctors better understand and manage neutropenic sepsis—a serious infection risk when white blood cell counts are too low. You may be considered if you develop fever or sepsis quickly (within 24 hours) while your counts are low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can give consent, or a suitable representative can if you cannot
- Your lab results show low neutrophils (ANC under 500) or, if ANC isn’t available, high enough to qualify as low white cells (WBC under 1000)
- You have fever or sepsis that started less than 24 hours ago
- This is your first qualifying episode during this hospital stay (not a second fever episode)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether proteins in your blood can predict complications when you have a fever and very low white blood cells after cancer treatment. It aims to help doctors choose the best antibiotics early on.
This study tests whether adults with “high-risk febrile neutropenia” can safely get a shorter course of antibiotics. It may help reduce side effects from antibiotics while still keeping infections under control.
This trial tests a medical device (NucleoCapture) that may remove substances called circulating DNA and NETs from the blood in people with sepsis and breathing failure. The goal is to check safety and see whether it can improve blood markers and possibly outcomes.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
Hear when a new Febrile Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.